Background Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are a
frequent cause of invasive infections worldwide. Carbapenems are nowadays the most used …

The role of fosfomycin for multidrug-resistant gram-negative... : Current Opinion in Infectious
Diseases The role of fosfomycin for multidrug-resistant gram-negative infections : Current …

Previously, by targeting penicillin-binding protein 3, Pseudomonas-derived
cephalosporinase (PDC), and MurA with ceftazidime-avibactam-fosfomycin, antimicrobial …

Introduction: Carbapenems have an important place in our antibiotic armamentarium and
have been trusted to effectively treat infections caused by ESBL-producing …

Optimizing therapy of bloodstream infection due to extended-... : Current Opinion in Critical
Care Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing …

Fosfomycin was initially discovered in 1969 but has recently gained renewed interest for the
treatment of multidrug‐resistant (MDR) bacterial infections, particularly in the United States …

Fosfomycin is a bactericidal antibiotic that interferes with cell wall synthesis. The drug
therefore has a broad spectrum of activity against a wide range of Gram-positive and Gram …

Fosfomycin is a bactericidal antibiotic available since the 1970s whose intravenous
formulation has been available in many countries outside the USA. Given the rise in drug …

CMI. Sin embargo, se podría optimizar el cociente PK/PD en la práctica diaria en la función
del patógeno, el perfil clínico del paciente o el modelo de infección. Fosfomicina es el …